[Ip-health] Synexus extends patient outreach through GP sales force

[Joana Ramos]

http://www.synexus.co.uk/news--media/news/synexus-extends-patient-outreach-=
through-gp-sales-force.aspx

Synexus extends patient outreach through GP sales force

05 February 2009

Synexus has extended its ability to find more patients to take part in
clinical trials in the UK through the launch of a GP practice sales force.

The sales force, initially comprising five clinical trial experts, will
call on GPs surrounding the seven Synexus clinical sites in the UK. GPs
are keen to be involved with clinical trials but lack the time and
increasingly the specialised equipment now required in many trials. This
partnership with Synexus allows them to become involved in the latest
treatments whilst not compromising on their service to their own patients.

Synexus, who is a world leader in the recruitment of patients into
clinical trials at its own research centres in Europe, Africa and Asia,
is looking at rolling this out across its sites in Europe.

Synexus who recently found more than three thousand patients for a
single study is developing a range of sophisticated tools to talk to
patients about taking part in clinical trials.

Michael Fort, Chief Executive of Synexus, explains =93The Synexus model of
having our own clinical sites which are staffed by full time trained
investigators has led to a huge demand for our services from pharma,
bios and CROs. This new development of extending our outreach to GPs
through this partnership agreement is just one of several new
initiatives we are putting in place to reach patients=94.

- ENDS -

Notes to editors:


Synexus=AE headquartered in Manchester, England, is the world=92s largest
multi-national company dedicated to the recruitment and running of late
stage clinical trials by full time GCP trained investigators at its own
clinical trial sites.

Synexus=AE recruits participants for clinical trials on behalf of
pharmaceutical, biotech and CROs. The clinical trials are then run and
managed by Synexus=AE at 16 sites across the UK, Poland, Hungary,
Bulgaria, India and South Africa.

Synexus=AE currently has more than ten thousand patients enrolled in
clinical trials.


----------------------
Joana Ramos, MSW
Cancer Resources & Advocacy
Seattle WA USA
+1-206-229-2420
http://ramoslink.info/
www.bmtbasics.org
www.healthyskepticism.org